Use of meglumine antimoniate in canine leishmaniasis [2]

Veterinary Record

Volumn 154, Issue 12, 2004, Pages 378-

  Lamothe, Jacques ^a  

^a CLINIQUE VÉTÉRINAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; MEGLUMINE ANTIMONATE;

ASIA; DISEASE TRANSMISSION; DOG DISEASE; DRUG EFFICACY; LEISHMANIA INFANTUM; LEISHMANIASIS; LETTER; NONHUMAN; PSYCHODIDAE; SOUTH AND CENTRAL AMERICA; SOUTHERN EUROPE; ZOONOSIS;

ADULT; ANIMALS; ANTIPROTOZOAL AGENTS; DOG DISEASES; DOGS; HUMANS; INFANT; LEISHMANIASIS, CUTANEOUS; MEGLUMINE; ORGANOMETALLIC COMPOUNDS;

CANIS FAMILIARIS; LEISHMANIA INFANTUM; PSYCHODIDAE;

EID: 1842607222     PISSN: 00424900     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. CARRIO, J., RIERA, C., GALLEGO, M. & PORTUS, M. (2001) In vitro activity of pentavalent antimony derivatives on promastigotes and intracellular amastigotes of Leishmania infantum strains from humans and dogs in Spain. Acta Tropica 79, 179-183
2. DESJEUX, P. (1996) Leishmaniasis. Public health aspects and control. Clinical Dermatology 14, 417-423
3. FARAUT-GAMBARELLI, F., PIARROUX, R., DENIAU, M., GIUSIANO, B., MARTY, P., MICHEL, G., FAUGERE, B. & DUMON, H. (1997) In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: A study of 37 strains collected from patients with visceral leishmaniasis. Antimicrobial Agents and Chemotherapy 41, 827-830
4. GRAMICCIA, M., GRADONI, L. & ORSINI, S. (1992) Decreased sensitivity to meglumine antimoniate (Glucantime) of Leishmania infantum isolated from dogs after several courses of drug treatment. Annals of Tropical Medicine and Parasitology 86, 613-620
5. SLAPPENDAL, R. J. & TESKE, E. (1999) A review of canine leishmaniasis presenting outside endemic areas. In Canine Leishmaniasis: an Update. Proceedings of a Canine Leishmaniasis Forum. Ed R. Killick-Kendrick. Barcelona, Intervet. pp 54-59